ADIAL PHARMACEUTICALS, INC. - Common stock, par value $0.0001 per share (ADIL) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2023 to Q4 2025

Type / Class
Equity / Common stock, par value $0.0001 per share
Symbol
ADIL on Nasdaq
Shares outstanding
28,024,454
Price per share
$0.21
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
3,536,220
Total reported value
$777,925
% of total 13F portfolios
0%
Share change
+2,928,137
Value change
+$643,610
Number of holders
22
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of ADIAL PHARMACEUTICALS, INC. - Common stock, par value $0.0001 per share (ADIL) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ARMISTICE CAPITAL, LLC 10% $587,925 2,799,643 Armistice Capital, LLC 31 Dec 2025
INTRACOASTAL CAPITAL, LLC 2.8% $325,786 446,282 Mitchell P. Kopin 17 Jun 2025

As of 31 Dec 2025, 22 institutional investors reported holding 3,536,220 shares of ADIAL PHARMACEUTICALS, INC. - Common stock, par value $0.0001 per share (ADIL). This represents 13% of the company’s total 28,024,454 outstanding shares.

Top 23 Institutional Shareholders

The largest institutional shareholders of ADIAL PHARMACEUTICALS, INC. - Common stock, par value $0.0001 per share (ADIL) together control 13% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
ARMISTICE CAPITAL, LLC 9.1% 2,554,442 0.01% $561,977
CITADEL ADVISORS LLC 0.78% 219,621 +53% 0% $48,317
VANGUARD GROUP INC 0.56% 156,024 0% 0% $34,325
GEODE CAPITAL MANAGEMENT, LLC 0.56% 155,745 -5.1% 0% $34,263
JANE STREET GROUP, LLC 0.43% 121,841 +887% 0% $26,805
NORTHERN TRUST CORP 0.24% 65,979 0% $14,515
Virtu Financial LLC 0.23% 63,827 0% $14,000
XTX Topco Ltd 0.19% 52,097 0% $11,461
Manchester Capital Management LLC 0.17% 48,097 0% 0% $10,582
BlackRock, Inc. 0.1% 27,770 0% 0% $6,109
StoneX Group Inc. 0.07% 19,451 0% $4,279
TWO SIGMA SECURITIES, LLC 0.06% 17,074 +33% 0% $3,756
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.04% 12,087 0% $2,659
PRIVATE MANAGEMENT GROUP INC 0.04% 10,000 0% 0% $2,200
UBS Group AG 0.03% 9,167 -51% 0% $2,017
Tower Research Capital LLC (TRC) 0% 1,341 -2.1% 0% $295
SBI Securities Co., Ltd. 0% 1,158 -17% 0% $255
BANK OF AMERICA CORP /DE/ 0% 204 +13% 0% $45
WELLS FARGO & COMPANY/MN 0% 160 0% 0% $35
HARBOUR INVESTMENTS, INC. 0% 99 0% $22
Abound Wealth Management 0% 27 0% 0% $6
MORGAN STANLEY 0% 9 0% 0% $2
HRT FINANCIAL LP 0% 0 -100% $0

Institutional Holders of ADIAL PHARMACEUTICALS, INC. - Common stock, par value $0.0001 per share (ADIL) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 3,536,220 $777,925 +$643,610 $0.22 22
2025 Q3 608,083 $214,070 +$133,627 $0.35 16
2025 Q2 234,705 $70,153 -$9,760 $0.30 16
2025 Q1 234,640 $149,046 -$82,917 $0.63 12
2024 Q4 289,676 $292,303 +$95,706 $1.01 13
2024 Q3 194,053 $193,859 -$98,515 $1.00 11
2024 Q2 283,661 $325,599 +$119,966 $1.15 13
2024 Q1 176,048 $233,389 -$211,877 $1.33 13
2023 Q4 264,302 $491,452 +$385,501 $1.86 14
2023 Q3 56,961 $158,346 +$158,346 $2.78 8